Rasagiline Mesylate Tablet
Product Images NDC 23155-747

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline Mesylate (NDC 23155-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasa05 (Rasagiline05mg30s)

Rasa05 (Rasagiline05mg30s)
Each tablet of Rasagiline Tahlets contains 0.5 mg of rasagiline as Rasagiline mosylate. It is manufactured by INDOCO REMEDIES LTD and distributed by Avet Pharmaceuticals Inc. The tablets are to be stored at 25°C (77°F) with excursions permitted to 15° o 30 59°t086°F. It is a prescription medicine and the dosage and prescribing information can be found on the accompanying package.*
FDA Label Image

Rasa1mg (Rasagiline1mg30s)

Rasa1mg (Rasagiline1mg30s)
This text provides information regarding a medication called Rasagiline Tablets. The National Drug Code (NDC) is 23155-747-03. Dosage information is not provided and must be obtained from prescribing information. The medication is manufactured by Indoco Remedies Ltd in India and distributed by Avet Pharmaceuticals in New Jersey. The medication should be stored at 25°C (77°F) with excursions between 15° to 30°C (59° to 86°F) permitted. The text also includes a code and a reference to USP Controlled Room Temperature.*
FDA Label Image

Str (Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.